Mettler-Toledo International Inc (MTD)
OvervaluedFundamental
62
Price
$1509.34
Market Cap
$30.96B
Part 1 · What the company is worth
Overview
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on September 19, 2026 with claude-haiku-4-5 — shared with all users
Thermo Fisher supplies the same laboratory customers with overlapping lines of analytical instruments, pipettes and process analytics, and competes for the large multi-year supply contracts of pharmaceutical and biotech labs.
Agilent competes for the same analytical-chemistry budget in pharmaceutical and industrial quality-control labs, with chromatography, spectroscopy and lab software that substitute for Mettler-Toledo's analytical instruments.
Waters sells chromatography, mass spectrometry and thermal-analysis systems to the same regulated pharmaceutical and materials laboratories where Mettler-Toledo places its thermal analysis and titration instruments.
Through its life-sciences and diagnostics brands Danaher bids for the same laboratory and bioprocessing equipment, consumables and service contracts, often bundling them across global accounts.
Sartorius is the closest head-to-head rival in laboratory weighing, selling analytical and precision balances, pipettes and lab consumables to the same pharmaceutical, chemical and academic laboratories.
Shimadzu builds balances, moisture analyzers and analytical instruments for the same industrial and laboratory customers, and is the main rival for Mettler-Toledo in Japan and much of Asia.
Balance Sheet & Liquidity
Revenue
$4.13B
Trailing 12 months (through 6/30/2026)
Net Income
$906M
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$849M
Total Equity
$-24M
Total Liabilities
$3.74B
Current Ratio
1.12
Interest Coverage
-
Debt/EBITDA
1.66
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$1181.36
Current Price
$1509.34
Margin of Safety
-27.8%
Fair Value Range
$820.70 - $1542.03
Spread across the valuation methods used, not a statistically calibrated confidence interval.
Estimation Methods
Valuation Metrics
P/E Ratio
34.06
ROE
-3677.4%
P/B Ratio
2360.93
P/FCF
35.04
Gross Margin
60.3%
ROIC
-
Profitability Radar
Value Creation (Economic Moat)
ROIC
-
WACC
10.6%
ROIC − WACC
-
Fundamental Analysis Criteria
Passed (17)
- EPS shows upward trend
- EPS CAGR 12.37%
- Price CAGR 11.95%
- Gross Margin 60.3%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 1816.3%
- Revenue Growth 5Y 5.5%
- Analyst Consensus 53% Buy
- Earnings Surprise avg 3.4%
- Earnings Quality (OCF/NI) 1.08
- Share Dilution -3.1%
- Net Margin Trend 21.9% vs 21.5%
- Piotroski F-Score 6/9
Failed (6)
- P/FCF 35.04
- P/B Ratio 2360.93
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- PEG Ratio 3.05
Unavailable (5)
- ROIC NaN%
- Dividend Payout NaN%
- Debt/Equity ratio
- Operating Margin NaN%
- Interest Coverage
Piotroski F-Score
Mixed signals: some areas need attention
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Institutional Holdings
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Patrick K. Kaltenbach | President & CEO | 62 |
| Mr. Shawn P. Vadala | Chief Financial Officer | 56 |
| Ms. Susan Graham-Bryce | Chief Human Resources Officer | 49 |
| Mr. Marc de La Gueronniere | Head of European & North American Market Organizations | 61 |
| Mr. Richard Wong | Head of Asia/Pacific | 59 |
| Mr. Markus Koepfli | Chief Information Officer | - |
| Mr. Adam William Uhlman | Head of Investor Relations | - |
| Ms. Michelle M. Roe | Chief Legal Officer & Corporate Secretary | 54 |
| Mr. Oliver Wittorf | Head of Product Inspection, Retail & Global Supply Chain | 49 |
| Mr. Gerhard Keller | Head of Process Analytics | 56 |
Audit Risk
2
Board Risk
1
Compensation Risk
6
Shareholder Rights Risk
5
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Documents
- View document
Annual Report (10-K)
A yearly overview of the business, its financial results, and the risks it faces.
Filed on 2026-02-06
- View document
Quarterly Report (10-Q)
A snapshot of financial performance for the most recent three-month period.
Filed on 2026-07-31
- View document
Current Report (8-K)
An announcement of a major event, such as a leadership change or big news.
Filed on 2026-08-03
via SEC EDGAR
Income History
via SEC EDGAR
Latest News
Recent headlines for MTD, sourced from Markets Gazette.